Octave
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
About Octave
Octave develops and offers a blood-based diagnostic platform focused on measuring disease activity in neurodegenerative conditions. It provides the Octave MSDA Test, a multi-analyte biomarker assay that quantifies levels of multiple proteins to assess activity in multiple sclerosis. The company supports clinicians and patients by transforming biomarker data into individualized reports that inform treatment decisions. It continues to expand research into additional biomarkers and disease progression models in neurodegeneration.
Company Facts
- Headquarters
- Menlo Park
- Founded
- 2014
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- late_stage_venture
- Total Funding
- $142,100,070
- Last Funding Type
- grant
- Last Funding Date
- 2025-10-06
- Website
- http://www.octavebio.com
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Health Diagnostics, Medical, Precision Medicine
Social Links
Canonical: https://fsome.com/organization/octave-14996 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.